Newsroom

latest news from ose
and across our portfolio

Featured News

Oxford Spinout Oxford Semantic Technologies acquired by Samsung Electronics
Oxford Spinout Oxford Semantic Technologies acquired by Samsung ElectronicsArticle links to www.oxionics.com
Oxford Ionics breaks global quantum performance records
Oxford Ionics breaks global quantum performance records
Times Commentary: Science innovation must be at the heart of government action
Times Commentary: Science innovation must be at the heart of government actionArticle links to www.beacontx.com
Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene Therapies
Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene TherapiesArticle links to www.prnewswire.com
PQShield raises $37m in Series B funding to deliver the widespread commercial adoption of quantum resistant cryptography
PQShield raises $37m in Series B funding to deliver the widespread commercial adoption of quantum resistant cryptographyArticle links to www.globenewswire.com
Amber Therapeutics Closes $100 Million Series A - one of the largest European MedTech raises
Amber Therapeutics Closes $100 Million Series A - one of the largest European MedTech raisesArticle links to www.businesswire.com
SpyBiotech Adds Epstein-Barr Virus Research and Development Collaboration with The University of Oxford
SpyBiotech Adds Epstein-Barr Virus Research and Development Collaboration with The University of Oxford
OSE announces groundbreaking new partnership with The Crown Estate and Pioneer Group
OSE announces groundbreaking new partnership with The Crown Estate and Pioneer Group

All News

Portfolio NewsGenomicsGenomics plc Announces David Thornton as PresidentPortfolio NewsGenomicsGenomics and GSK establish precision medicine collaboration to assess polygenic risk scores in clinical trial designPortfolio NewsGenomicsGenomics plc and MassMutual's program enables more policyowners to understand health risks through innovative genetic testingPortfolio NewsGenomicsGenomics publishes results of NHS trial in European Journal of Preventative CardiologyPortfolio NewsGenomicsGenomics raises £35mn for advanced genetic testingPortfolio NewsGenomicsGenomics announces successful world-first pilot using improved genomic risk assessment in cardiovascular disease prevention in the NHSPortfolio NewsGenomicsGenomics announces genetic risk scoring partnership with Our Future Health to test new personalised disease prevention approachesPortfolio NewsGenomicsGenomics announces that Simon Dingemans has joined its board as the new chairPortfolio NewsGenomicsGenomics academic founder and CEO, Sir Peter Donnelly, awarded Royal Society Gabor medalPortfolio NewsGenomicsGenomics completes oversubscribed $30m funding round